Long-term safety of nine systemic medications for psoriasis: A cohort study using the Spanish Registry of Adverse Events for Biological Therapy in Dermatological Diseases (BIOBADADERM) Registry
Sign Up to like & getrecommendations! Published in 2020 at "Journal of The American Academy of Dermatology"
DOI: 10.1016/j.jaad.2020.03.033
Abstract: Background Registry studies broadly describing the safety of systemic drugs in psoriasis are needed. Objective To describe the safety findings of the systemic drugs acitretin, adalimumab, apremilast, cyclosporine, etanercept, infliximab, methotrexate, secukinumab, and ustekinumab used… read more here.
Keywords: registry; registry adverse; psoriasis; adverse events ... See more keywords